Practical Considerations Relating to Routine Clinical Biomarker Testing for Non–small Cell Lung Cancer: Focus on Testing for RET Fusions

For patients with advanced non–small cell lung cancer, genomic profiling of tumors to identify potentially targetable alterations and thereby inform treatment selection is now part of standard care. While molecular analyses are primarily focused on actionable biomarkers associated with regulatory ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Herbst, Roy S., Aisner, Dara L., Sonett, Joshua R., Turk, Andrew T., Weintraub, Joshua L., Lindeman, Neal I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859651/
https://www.ncbi.nlm.nih.gov/pubmed/33553195
http://dx.doi.org/10.3389/fmed.2020.562480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859651/
https://www.ncbi.nlm.nih.gov/pubmed/33553195
http://dx.doi.org/10.3389/fmed.2020.562480

Ejemplares similares